Please login to the form below

Not currently logged in
Email:
Password:

KOL Strategy

This page shows the latest KOL Strategy news and features for those working in and with pharma, biotech and healthcare.

New accounts: September

Aranesp KOL strategy. Oncology. central. Amgen European HQ. Mimpara meetings. Nephrology. ... central. Amgen European HQ. Neulasta KOL strategy. Oncology. central. Baxter Healthcare UK.

Latest news

  • New accounts: October

    Amgen European HQ. Aranesp KOL strategy. Oncology. central. Amgen European HQ. ... Mimpara meetings. Nephrology. central. Amgen European HQ. Neulasta KOL strategy. Oncology.

  • New accounts: November

    Allergan. Botox. Neurology. Jango Communications. Amgen European HQ. Aranesp KOL strategy. ... Neulasta KOL strategy. Oncology. central. GlaxoSmithKline. Cervarix. Cervical cancer (consumer healthcare).

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics